Saskia Bresch

780 total citations
22 papers, 240 citations indexed

About

Saskia Bresch is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology. According to data from OpenAlex, Saskia Bresch has authored 22 papers receiving a total of 240 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 9 papers in Neurology and 4 papers in Rheumatology. Recurrent topics in Saskia Bresch's work include Multiple Sclerosis Research Studies (8 papers), Myasthenia Gravis and Thymoma (5 papers) and Peripheral Neuropathies and Disorders (4 papers). Saskia Bresch is often cited by papers focused on Multiple Sclerosis Research Studies (8 papers), Myasthenia Gravis and Thymoma (5 papers) and Peripheral Neuropathies and Disorders (4 papers). Saskia Bresch collaborates with scholars based in France, Monaco and Switzerland. Saskia Bresch's co-authors include Mikaël Cohen, Christine Lebrun‐Frénay, Michel Ticchioni, Michaël Levraut, Barbara Seitz‐Polski, Claude Desnuelle, Véronique Bourg, Maria Alessandra Rosenthal‐Allieri, Lydiane Mondot and Laurent Suissa and has published in prestigious journals such as Frontiers in Immunology, Journal of Neuroimmunology and Journal of Neurology.

In The Last Decade

Saskia Bresch

16 papers receiving 238 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Saskia Bresch France 10 120 96 68 45 38 22 240
Verena Kraus Germany 9 216 1.8× 219 2.3× 81 1.2× 44 1.0× 35 0.9× 13 334
Johanna Oechtering Switzerland 12 115 1.0× 200 2.1× 63 0.9× 24 0.5× 86 2.3× 22 358
Laura Piccolo Italy 11 206 1.7× 169 1.8× 59 0.9× 42 0.9× 47 1.2× 17 378
Frederik Bartels Germany 11 128 1.1× 69 0.7× 28 0.4× 22 0.5× 29 0.8× 18 249
Shunsuke Yoshimura Japan 8 120 1.0× 69 0.7× 56 0.8× 31 0.7× 58 1.5× 37 252
Ángel I Pérez-Álvarez Spain 10 39 0.3× 76 0.8× 62 0.9× 24 0.5× 59 1.6× 29 279
Cristina Valencia-Sánchez United States 12 239 2.0× 116 1.2× 40 0.6× 46 1.0× 55 1.4× 30 379
Jen-Jen Su Taiwan 6 76 0.6× 101 1.1× 66 1.0× 17 0.4× 90 2.4× 17 321
Witold Palasik Poland 8 96 0.8× 71 0.7× 47 0.7× 25 0.6× 46 1.2× 23 261
Alessandra Protti Italy 8 145 1.2× 83 0.9× 22 0.3× 25 0.6× 21 0.6× 21 259

Countries citing papers authored by Saskia Bresch

Since Specialization
Citations

This map shows the geographic impact of Saskia Bresch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saskia Bresch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saskia Bresch more than expected).

Fields of papers citing papers by Saskia Bresch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saskia Bresch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saskia Bresch. The network helps show where Saskia Bresch may publish in the future.

Co-authorship network of co-authors of Saskia Bresch

This figure shows the co-authorship network connecting the top 25 collaborators of Saskia Bresch. A scholar is included among the top collaborators of Saskia Bresch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saskia Bresch. Saskia Bresch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bresch, Saskia, Miriam Freimer, Channa Hewamadduma, et al.. (2025). P.107 Early and sustained response over time with zilucoplan in generalised Myasthenia Gravis: 120-week post hoc analysis of RAISE-XT. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 52(s1). S40–S40.
2.
Bresch, Saskia, et al.. (2024). French validation of the sexual complaints screener (SCS) for patients with multiple sclerosis. Revue Neurologique. 181(1-2). 85–92.
3.
Bresch, Saskia, et al.. (2024). Rituximab alone is as effective as associated with steroids on naive patients with generalized myasthenia gravis. Journal of Neurology. 271(8). 5197–5202. 1 indexed citations
4.
Levraut, Michaël, Mikaël Cohen, Saskia Bresch, et al.. (2023). Kappa Free Light Chain Index Predicts Disease Course in Clinically and Radiologically Isolated Syndromes. Neurology Neuroimmunology & Neuroinflammation. 10(6). 21 indexed citations
5.
Cohen, Mikaël, et al.. (2023). Early treatment with rituximab in Susac syndrome. Revue Neurologique. 180(3). 230–235.
6.
Farmakidis, Constantine, Maria Isabel Leite, Saskia Bresch, et al.. (2023). P273 Long-term safety, efficacy & self-injection satisfaction with zilucoplan in myasthenia gravis: RAISE-XT interim analysis. Neuromuscular Disorders. 33. S178–S178. 1 indexed citations
7.
Cohen, Mikaël, et al.. (2022). Reliability of mobile video-oculography in multiple sclerosis patients using an iPad: A prospective validation study. Multiple Sclerosis and Related Disorders. 64. 103944–103944. 4 indexed citations
8.
Levraut, Michaël, Lydiane Mondot, Mikaël Cohen, et al.. (2022). Kappa Free Light Chains, Soluble Interleukin-2 Receptor, and Interleukin-6 Help Explore Patients Presenting With Brain White Matter Hyperintensities. Frontiers in Immunology. 13. 864133–864133. 9 indexed citations
9.
Cohen, Mikaël, et al.. (2021). Should we still only rely on EDSS to evaluate disability in multiple sclerosis patients? A study of inter and intra rater reliability. Multiple Sclerosis and Related Disorders. 54. 103144–103144. 28 indexed citations
10.
Bresch, Saskia, Barbara Seitz‐Polski, Claude Desnuelle, et al.. (2021). Memory B Cells Predict Relapse in Rituximab-Treated Myasthenia Gravis. Neurotherapeutics. 18(2). 938–948. 14 indexed citations
11.
Bresch, Saskia, et al.. (2021). Papilledema secondary to vestibular schwannoma: An atypical case without intracranial hypertension. Neurochirurgie. 68(3). 327–330.
12.
Mondot, Lydiane, et al.. (2020). Thalamic atrophy correlates with dysfunctional impulsivity in multiple sclerosis. Multiple Sclerosis and Related Disorders. 44. 102374–102374. 5 indexed citations
13.
Cohen, Mikaël, et al.. (2019). Impact of executive dysfunction on naming ability in multiple sclerosis. Revue Neurologique. 175(9). 552–559. 4 indexed citations
14.
Bousson, V., Karine Viala, Yann Péréon, et al.. (2019). Prospective study of the additional benefit of plexus magnetic resonance imaging in the diagnosis of chronic inflammatory demyelinating polyneuropathy. European Journal of Neurology. 27(1). 181–187. 15 indexed citations
15.
Lebrun‐Frénay, Christine, Mikaël Cohen, Maria Alessandra Rosenthal‐Allieri, et al.. (2018). Only Follow-Up of Memory B Cells Helps Monitor Rituximab Administration to Patients with Neuromyelitis Optica Spectrum Disorders. Neurology and Therapy. 7(2). 373–383. 31 indexed citations
16.
Lebrun‐Frénay, Christine, et al.. (2018). Digestive side-effects with teriflunomide: Thoughts on lactose. Revue Neurologique. 174(10). 722–725.
17.
Lebrun‐Frénay, Christine, Véronique Bourg, Saskia Bresch, et al.. (2016). Therapeutic target of memory B cells depletion helps to tailor administration frequency of rituximab in myasthenia gravis. Journal of Neuroimmunology. 298. 79–81. 35 indexed citations
18.
19.
Suissa, Laurent, et al.. (2012). Brain Natriuretic Peptide: A Relevant Marker to Rule Out Delayed Atrial Fibrillation in Stroke Patient. Journal of Stroke and Cerebrovascular Diseases. 22(7). e103–e110. 23 indexed citations
20.
Bresch, Saskia, et al.. (2011). Anomalies hématologiques du natalizumab et sa signification clinique. Revue Neurologique. 168(2). 116–120.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Verena Kraus Breakdown of academic impact, for papers by Johanna Oechtering Breakdown of academic impact, for papers by Laura Piccolo Breakdown of academic impact, for papers by Frederik Bartels Breakdown of academic impact, for papers by Shunsuke Yoshimura Breakdown of academic impact, for papers by Ángel I Pérez-Álvarez Breakdown of academic impact, for papers by Cristina Valencia-Sánchez Breakdown of academic impact, for papers by Jen-Jen Su Breakdown of academic impact, for papers by Witold Palasik Breakdown of academic impact, for papers by Alessandra Protti
Rankless by CCL
2026